Friday, July 10, 2026

pharma · Obese · Hyperlipemia

Suzhou Ribo Life

Suzhou Ribo Life trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Beijing, CN HQ
2007 Founded
32 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Beijing, CN
Founded
2007
Employees
32
Programs
4
Drugs
7
Patents
0
Intelligence · Clinical Trials

Suzhou Ribo Life clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Suzhou Ribo Life programs — each row shows trial ID, program name, phase, status, and indication.

Suzhou Ribo Life trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Suzhou Ribo Life.

  1. Dose escalation of SA030 — Phase 1

    Clinical update
  2. SHR-A2009 ; Aumolertinib — Phase 3

    Clinical update
  3. RBD7022 — Phase 1

    Clinical update
  4. UTAA91 injection — Phase 1

    Clinical update

Trial registry

4 studies